In some cases, more to Alzheimer’s than just amyloids
By Anette Breindl
Thursday, April 3, 2014
Researchers have identified a biochemical pathway that destabilizes spines in knock-in mice bearing a protein linked to some cases of familial Alzheimer’s disease (AD). The work suggests a novel therapeutic approach to AD and age-related memory loss that is independent of the amyloid-beta processing approaches at the oft-broken heart of current drug trials. The findings were published in the April 2, 2014, issue of Neuron. Senior author Ilya Bezprozvanny, who is at the University of Texas Southwestern Medical Center, told BioWorld Today that beyond their practical possibilities, the results support his contention that there is a lot more to AD than amyloid-beta.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.